NEWS AND VIEWS
Digital insulin management company Hygieia closes on $17 million Series B investment round
Funding will enable expansion of company’s AI-driven d-Nav® technology, which automates real-time insulin dose recommendations for people with type 2 diabetes LIVONIA, Mich., December 2, 2021 – Hygieia, a digital health company for insulin management, has closed on an initial $17 million Series B investment round, led by Israeli venture capital firm Firstime Ventures, and with participation from…
The d-Nav® Program Featured on WXYZ TV
Two thirds of people who take insulin for type 2 diabetes do not have their blood sugar in the desired range. Andrea Isom from WXYZ TV 7 in Detroit talked with Hygieia CEO and Co-Founder Eran Bashan and d-Nav patient Marty Cook to find out how the d-Nav technology helps Marty, and potentially millions of…
JOIN OUR NETWORK
Discover the latest insights and views about type 2 diabetes.
RESEARCH & STUDIES
Explore d-Nav studies, peer-reviewed papers, white papers and more.
PRESS INQUIRIES
Reinheimer PR & Marketing